Novartis Investigative site

Nuneaton CV10 7DJ

0 studies enrolling now · 4 studies all time

What they study most

Chronic Plaque Psoriasis, Heart Failure With Reduced Ejection Fraction, Moderate and Severe Plaque Psoriasis, Moderate to Severe Plaque-type Psoriasis

Studies at this site

• Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis — Completed
• A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis — Completed
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab — Completed
• Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients — Completed